High STAT5 expression levels have been shown not only to enhance IM resistance in CML cells but also to trigger BCR-ABL mutations by inducing the production of reactive oxygen species (ROS) responsible for DNA damage [8,9]. Here, STAT5A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.